Earnings Call · Q2 FY2021·2021-08-17

Q2 21EPS n/a·Rev n/aQ1 21EPS n/a·Rev n/aQ4 20EPS n/a·Rev n/aQ3 20EPS n/a·Rev n/a⚠ consensus missing

NRX Pharmaceuticals, Inc. NRXP

Eric Goldstein — Chief Financial Officer (CFO)

Jonathan Javitt — Chief Executive Officer (CEO)

Randy Guggenheimer — Chief Operating Officer (COO)

−15.2%1d on move date−15.4% vs SPY3d−1.1%5d−7.4%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more NRXP calls or request research access.

More NRXP calls Browse calls Request research access